Apollo Hospitals Q1FY27: Revenue Up 21% to ₹70,435 Crore, PAT Jumps 34% to ₹5,805 Crore
Apollo Hospitals Q1FY27 consolidated revenue grew 21% to ₹70,435 crore. PAT increased 34% to ₹5,805 crore. Healthcare Services revenue rose 22% to ₹35,670 crore. Apollo HealthCo revenue grew 22% to ₹29,770 crore, with digital cash loss reduced significantly. The company plans major expansion and has signed an MoU for air ambulances.
The announcement details significant financial growth across key segments and outlines substantial expansion plans, along with strategic collaborations, which are likely to have a material impact on the company's future performance and market position.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, indicating positive financial performance. Strategic initiatives and expansion plans further contribute to a positive outlook.
Apollo Hospitals Enterprise Limited announced its financial results for the first quarter ended June 30, 2026 (Q1FY27). The company reported a consolidated revenue of ₹70,435 crore, marking a significant 21% year-on-year growth. EBITDA also saw a substantial increase of 28% to ₹10,920 crore.
Consolidated Profit After Tax (PAT) surged by 34% to ₹5,805 crore. The Healthcare Services segment demonstrated robust performance with revenue growth of 22% to ₹35,670 crore, driven by a 13% increase in inpatient volume and an 8% rise in average revenue per inpatient.
The company is actively expanding its operational footprint, having commissioned 5 new hospitals in the last two quarters, adding approximately 1,000 census beds. Significant investments are planned for future expansion, with a total project cost of around ₹11,150 crore, of which approximately ₹7,500 crore is yet to be spent.
Apollo HealthCo, the digital health and pharmacy distribution arm, reported revenue growth of 22% to ₹29,770 crore. The company achieved its lowest digital cash loss of ₹97 crore in Q1FY27, a reduction of ₹390 crore year-on-year. The platform's Gross Merchandise Value (GMV) grew by 23% to ₹5,351 crore.
Apollo Hospitals also announced strategic initiatives, including an MoU with the ePlane Company to explore electric air ambulances and medical delivery drones. Several of its facilities received prestigious awards and recognitions for their quality of care and operational excellence.
What to do with a filing like this
Apollo Hospitals Enterprise Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Apollo Hospitals Enterprise Limited. Read the original for the full detail.